(・ω・) try 1ClickPost.com paste text to share free

Three FDA Approvals, NCI Director Resigns, and More

Say and pronounce Three FDA Approvals, on SuperTTS.com Make Your Own Text-To-Speech Words Instantly

  Info

Description

Laura Jones reports on the resignation of Harold Varmus, MD, and on FDA approvals for nivolumab, dinutuximab, and Zarxio, the first US biosimilar.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
Old Cartoons on DVD. Visit and Bookmark: Cool90s.com!

Related

  FDA Approvals in HCC and Gastric Cancer, ODAC Panel Splits on Adjuvant RCC Treatment, and More   Review on 2016 FDA Approvals, Halt on AML Trials, and More   FDA Approvals in CRC, Blood Diagnostic, and Alopecia, and More   Pharma CEOs meet at White House   FDA Approvals in Ovarian Cancer and Merkel Cell Carcinoma   FDA approves Mylan generic MS treatment   FDA Approvals, Breakthrough Designations, Priority Reviews, and More   FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and a Breakthrough Designation in NSCLC   FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and Breakthrough Designation in NSCLC   FDA Approvals for Daratumumab and Osimertinib, Regulatory Advances in RCC and CLL, and More   FDA Approves MM-398, T-VEC, and Trabectedin, New Pembrolizumab Data, and More   Dr. Kumar on Recent Advancements in the Field of Multiple Myeloma   FDA Head Says Agency Will Take Action to Lower Drug Prices   FDA Approvals in Breast Cancer and NSCLC, NDA Accepted in HCC, and More   FDA Approvals in NSCLC, Bladder Cancer, and Breast Cancer, and Death in CAR T-cell Therapy Trial   FDA Approvals in Breast Cancer and Melanoma, Disappointing Results in HNSCC, and More   FDA Approvals in ALL and Breast Cancer, Priority Reviews in CML and Follicular Lymphoma, and More   FDA Approvals in CRC, Blood Cancer Detection Diagnostic, and Alopecia, and More   FDA Approvals in ALL, Ovarian Cancer, Priority Review in CTCL, and sNDA Submitted in RCC   Key Considerations for Treating Recurrent Ovarian Cancer   Clinical Experience: CDK4/6 Inhibitors in Breast Cancer   FDA Approvals in GVHD, CRC, and AML, a Priority Review in MCL, and More   FDA Approvals in MSI-High Cancers, Priority Reviews in Gastric Cancer and FL, and More   FDA Approvals in Breast Cancer and Hodgkin Lymphoma, 2017 SGO Highlights, and More   FDA Approvals in Follicular Lymphoma and Prostate Cancer, Biosimilar Is Granted Approval, and More   Drug Research's Hottest Trend: Faster FDA Approvals   Full FDA Approvals in Breast Cancer and Lung Cancer, Priority Reviews in ALL, and More   American Lives Extended By Over 3 Million Years Because Of This   FDA Approvals in Hematologic Malignancies, sBLA Accepted in Multiple Myeloma, and More   Cumberland County Health Dept's nursing director resigns   Making changes   President Trump's communications director resigns   White House Communications Director Anthony Scaramucci resigns   New NCI Director, Early Release of Prostate Cancer Data, Disappointing Findings in RCC, and More   Ari Fleischer on why Trump is bringing Scaramucci to the WH   Cumberland Co. health director resigns after CBS North Carolina investigation   Cumberland County health director resigns following CBS North Carolina investigation   Major health bill would fund medical research, hasten FDA approvals   Big Announcement for Markey Cancer Center at UK   Ethics Chief Resigns After Repeated Clashes With Trump Administration   AP Top Stories for October 1 P   AP Top Stories for October 1 P   'The Five' reacts to shakeup at the White House   'The Five' reacts to shakeup at the White House   NCI Director Meets with Markey Researchers, Faculty during Special Visit   'Fasting-Mimicking' Diet Helps Overweight People In All Sorts Of Ways   Anthony Scaramucci Takes First Questions   Inside the latest White House staff wars   The FDA plans to reduce nicotine in cigarettes   Application of Pharmacogenomics in Drug Development, Regulatory Review and Clinical Practice   Dr. Alice P. Chen Provides an Overview of the NCI-MATCH Trial   Interview: Preparing for an FDA audit, with Grant Ramaley   FDA: Anesthesia Can Be Harmful to Children's Brains   Three more hardcore terrorists executed   Volunteering for a Phase 1 trial   Muhsin Yazıcıoğlu'nun Sevenleri Kabri Başına Koştu   Larry Curly & Moe talk The Three Stooges - JoBlo.com   Pioneering Treatment for Hypoplastic Left Heart Syndrome - Mayo Clinic   Ex-forestry department director claims trial to bribery charges   Alpena's 911 Director Gurisko Resigns   US intelligence head James Clapper resigns   White House spokesman Sean Spicer resigns: US media   Madison West athletic director resigns amid News 3 investigation   White House communications director resigns   President Trump's communications director resigns   White House communications director resigns   White House Communications Director Resigns   White House communications director resigns   One In Three Drugs Still Offer Safety Concerns After Passing FDA Approval   Death knell sounds for trans fat   Kevin Smith Explains His Three Year Film Hiatus   Treatment for primary progressive Multiple Sclerosis   మూడు రోజుల్లో అల్పపీడనం..   UC Davis Meets NCI-Designation With Great Responsibility   Vishal Sikka Resigns As Infosys Managing Director And CEO

Popular Today